ATRYS HEALTH (Germany) Performance
| A2T Stock | EUR 2.93 0.07 2.33% |
ATRYS HEALTH has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.03, which signifies a somewhat significant risk relative to the market. ATRYS HEALTH returns are very sensitive to returns on the market. As the market goes up or down, ATRYS HEALTH is expected to follow. ATRYS HEALTH SA currently shows a risk of 2.97%. Please confirm ATRYS HEALTH SA sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to decide if ATRYS HEALTH SA will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, ATRYS HEALTH is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
ATRYS |
ATRYS HEALTH Relative Risk vs. Return Landscape
If you would invest 292.00 in ATRYS HEALTH SA on December 18, 2024 and sell it today you would earn a total of 1.00 from holding ATRYS HEALTH SA or generate 0.34% return on investment over 90 days. ATRYS HEALTH SA is currently producing 0.0493% returns and takes up 2.9712% volatility of returns over 90 trading days. Put another way, 26% of traded stocks are less volatile than ATRYS, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
ATRYS HEALTH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATRYS HEALTH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ATRYS HEALTH SA, and traders can use it to determine the average amount a ATRYS HEALTH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0166
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | A2T |
Estimated Market Risk
| 2.97 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average ATRYS HEALTH is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATRYS HEALTH by adding it to a well-diversified portfolio.
ATRYS HEALTH Fundamentals Growth
ATRYS Stock prices reflect investors' perceptions of the future prospects and financial health of ATRYS HEALTH, and ATRYS HEALTH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ATRYS Stock performance.
| EBITDA | 6.68 M | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 71.4 M | |||
| Debt To Equity | 0.95 % | |||
| Book Value Per Share | 1.53 X | |||
| Cash Flow From Operations | (1.4 M) | |||
| Earnings Per Share | (0.05) X | |||
About ATRYS HEALTH Performance
By analyzing ATRYS HEALTH's fundamental ratios, stakeholders can gain valuable insights into ATRYS HEALTH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ATRYS HEALTH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ATRYS HEALTH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany.Things to note about ATRYS HEALTH SA performance evaluation
Checking the ongoing alerts about ATRYS HEALTH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ATRYS HEALTH SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ATRYS HEALTH SA has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.02 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ATRYS HEALTH SA has accumulated about 17.6 M in cash with (1.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51. |
- Analyzing ATRYS HEALTH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ATRYS HEALTH's stock is overvalued or undervalued compared to its peers.
- Examining ATRYS HEALTH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ATRYS HEALTH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ATRYS HEALTH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ATRYS HEALTH's stock. These opinions can provide insight into ATRYS HEALTH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ATRYS Stock analysis
When running ATRYS HEALTH's price analysis, check to measure ATRYS HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATRYS HEALTH is operating at the current time. Most of ATRYS HEALTH's value examination focuses on studying past and present price action to predict the probability of ATRYS HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATRYS HEALTH's price. Additionally, you may evaluate how the addition of ATRYS HEALTH to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |